<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01909622</url>
  </required_header>
  <id_info>
    <org_study_id>VDFORT</org_study_id>
    <nct_id>NCT01909622</nct_id>
  </id_info>
  <brief_title>Trial of Vitamin D Fortified Milk</brief_title>
  <official_title>A Randomized Trial of Milk Fortified With Vitamin D in Colombia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Michigan</source>
  <brief_summary>
    <textblock>
      Prevalence of VDD is high worldwide, even in sunbathed equatorial regions where it had not&#xD;
      been suspected before. The most cost-effective method for reducing population-wide VDD is&#xD;
      through fortification of commonly consumed foods. Nevertheless, the efficacy of fortification&#xD;
      varies by dose, duration, and population characteristics; and it is currently unknown whether&#xD;
      it could be an efficacious public health intervention to curb the VDD epidemic among children&#xD;
      living in tropical areas. We propose to conduct a randomized, controlled, double blind trial&#xD;
      to assess the effect of vitamin D3 fortification of milk on serum 25-hydroxyvitamin D&#xD;
      concentrations in school-age children and their mothers in Bogot√°, Colombia. Eighty families&#xD;
      with a child participating in an ongoing cohort study will be randomized to receive one liter&#xD;
      per day of either skim milk fortified with 600 IU vitamin D3 per 250mL or unfortified skim&#xD;
      milk for a six-week period. Caregivers will be instructed to give the index child two cups of&#xD;
      milk per day and to distribute the remaining milk to the rest of the family. We will measure&#xD;
      serum 25(OH)D concentrations of the children and mothers at baseline and at the end of the&#xD;
      intervention period.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum concentrations of 25-OH vitamin D</measure>
    <time_frame>up to 6 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>25-hydroxyvitamin D Serum Concentrations</condition>
  <arm_group>
    <arm_group_label>Vitamin D-fortified milk</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Skim milk fortified with 600 IU vitamin D3 / 250 mL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin D-unfortified milk</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Unfortified skim milk</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D</intervention_name>
    <arm_group_label>Vitamin D-fortified milk</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>No vitamin D</intervention_name>
    <arm_group_label>Vitamin D-unfortified milk</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age between 144 and 174 completed months by the time of enrollment.&#xD;
&#xD;
          2. Intention to stay in the city for the next six weeks.&#xD;
&#xD;
          3. Children living with their biological mothers.&#xD;
&#xD;
          4. Families own a refrigerator.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. History of illness involving calcium or bone metabolism, including stones of the&#xD;
             urinary tract.&#xD;
&#xD;
          2. Currently taking vitamin D supplements as treatment of any disease.&#xD;
&#xD;
          3. Receiving immunosuppressive therapy (oral corticosteroids, chemotherapy) during the&#xD;
             previous year.&#xD;
&#xD;
          4. Known history of lactose intolerance or other contra-indications or aversion to milk&#xD;
             intake.&#xD;
&#xD;
          5. Known hypercalcemia.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>144 Months</minimum_age>
    <maximum_age>174 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mercedes Mora, MSc, RD</last_name>
    <role>Study Director</role>
    <affiliation>FINUSAD - Foundation for Research in Nutrition and Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Henry Oliveros, MD, MSc</last_name>
    <role>Study Director</role>
    <affiliation>University of La Sabana</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eduardo Villamor, MD, DrPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>FINUSAD - Foundation for Research in Nutrition and Health</name>
      <address>
        <city>Bogota</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of La Sabana</name>
      <address>
        <city>Chia</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Colombia</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <study_first_submitted>July 24, 2013</study_first_submitted>
  <study_first_submitted_qc>July 25, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 26, 2013</study_first_posted>
  <last_update_submitted>October 25, 2016</last_update_submitted>
  <last_update_submitted_qc>October 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Eduardo Villamor</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Vitamin D</keyword>
  <keyword>Milk fortification</keyword>
  <keyword>Children</keyword>
  <keyword>Colombia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

